119 related articles for article (PubMed ID: 8792922)
1. Lack of subsensitivity to mizolastine over 8-week treatment.
Bousquet J; Chanal I; Murrieta M; Stalla-Bourdillon A
Allergy; 1996 Apr; 51(4):251-6. PubMed ID: 8792922
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of histamine-induced skin wheal and flare after 5 days of mizolastine.
Pinquier JL; Caplain H; Cabanis MJ; Dubruc C; Stalla-Bourdillon A; Rosenzweig P
J Clin Pharmacol; 1996 Jan; 36(1):72-8. PubMed ID: 8932546
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
Deschamps C; Dubruc C; Mentre F; Rosenzweig P
Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine.
Michel L; Murrieta-Aguttes M; Jean-Louis F; Levy D; Dubertret L
Ann Allergy Asthma Immunol; 2000 Jul; 85(1):64-9. PubMed ID: 10923607
[TBL] [Abstract][Full Text] [Related]
5. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
Purohit A; Mélac M; Pauli G; Frossard N
Br J Clin Pharmacol; 2002 Mar; 53(3):250-4. PubMed ID: 11874388
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of mizolastine in seasonal allergic rhinitis. The Rhinase Study Group.
Leynadier F; Bousquet J; Murrieta M; Attali P
Ann Allergy Asthma Immunol; 1996 Feb; 76(2):163-8. PubMed ID: 8595536
[TBL] [Abstract][Full Text] [Related]
7. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
Frèche C; Leynadier F; Horak F; Hide D; Gracia FD; Goos M; Bachert C; Horvath A; Antosova E; Verrecchia M; Soussen PB
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.
Bellioni P; Catalano B; Cervellera G; Filiaci F; Mira E; Carraro A
Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072
[TBL] [Abstract][Full Text] [Related]
10. Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group.
Bachert C; Brostoff J; Scadding GK; Tasman J; Stalla-Bourdillon A; Murrieta M
Allergy; 1998 Oct; 53(10):969-75. PubMed ID: 9821477
[TBL] [Abstract][Full Text] [Related]
11. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
13. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.
Leynadier F; Duarte-Risselin C; Murrieta M
Eur J Dermatol; 2000; 10(3):205-11. PubMed ID: 10725819
[TBL] [Abstract][Full Text] [Related]
14. Can an antihistamine delay appearance of hay fever symptoms when given prior to pollen season?
Stern MA; Darnell R; Tudor D
Allergy; 1997 Apr; 52(4):440-4. PubMed ID: 9188928
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
16. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation.
Simons FE
Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699
[TBL] [Abstract][Full Text] [Related]
17. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
Wang RQ; Zhang HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
[TBL] [Abstract][Full Text] [Related]
18. Lack of subsensitivity to loratadine during long-term dosing during 12 weeks.
Bousquet J; Chanal I; Skassa-Brociek W; Lemonier C; Michel FB
J Allergy Clin Immunol; 1990 Aug; 86(2):248-53. PubMed ID: 1974561
[TBL] [Abstract][Full Text] [Related]
19. Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H1-receptor antagonist.
Chaufour S; Caplain H; Lilienthal N; L'héritier C; Deschamps C; Dubruc C; Rosenzweig P
Br J Clin Pharmacol; 1999 May; 47(5):515-20. PubMed ID: 10336575
[TBL] [Abstract][Full Text] [Related]
20. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine.
Chosidow O; Dubruc C; Danjou P; Fuseau E; Espagne E; Bianchetti G; Thenot JP; Herson S; Rosenzweig P; Revuz J
Eur J Clin Pharmacol; 1996; 50(4):327-33. PubMed ID: 8803528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
